Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-824-2 | CAS number: 74-95-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
A standard toxicokinetic study could not be located. However, several scientific publications are available. All of them are well described and reliable (Klimisch2). Some of these publications are also cited in the US EPAHealth and Environmental Profile for Methylene Bromide (1987).
Absorption-
Oral route-Data regarding the gastrointestinal absorption of dibromomethane could not be located in the available literature. However, systemic effects which were observed following oral exposure points out that the substanceare absorbed by this route.
Inhalation route- Rats exposed by inhalation to 100mmol/ kg (17.4 mg/kg) dibromomethane in a closed rebreathing system exhaled ~70mmol/kg (~2mg/kg) of carbon monoxide above endogenous levels for 6 hours (Rodkey and Collison, 1977). Although these data indicate that dibromomethane was absorbed by the pulmonary route, some of the carbon monoxide production occurred in the lungs, as lung microsomes are capable of metabolizing dibromomethane to carbon monoxidein vitro.
Dermal route-McDougal et al. (1985) studied the dermal absorption of dibromomethane in male Fischer-344 rats in chambers that provided the rats with fresh air while their bodies were exposed to concentrations of dibromomethane ranging from 500-10,000 ppm. A jugular catheter provided the means for obtaining serial blood samples in which plasma levels of dibromomethane and bromide were measured. Dibromomethane was detected in blood within 20 minutes of the start of exposure at all levels and the plasma levels were concentration related, indicating absorbance through the skin.
McDougal et al. (1986) presented a method to determine a skin:air partition coefficient (PC) for volatile organic chemicals. Skin:air PC determined for dibromomethane is 68.3. This high PC value indicates that dibromomethane quickly enters the skin.
McDougal and Whitehead (2001) showed that following short time showering and bathing exposures of isolated rat skin (Fischer 344 strain) with dimromomethane for up to 20 minutes (a diffusion cell experiment), the absorption of the chemical into the skin was greater than the penetration of the chemical through the skin during the exposure. The amount of chemical in the skin was approximately eight times the amount that was in the receptor solution. Therefore, the amount of the chemical in the skin is the most important part of the body burden during showering or bathing.
Distribution-Data regarding the distribution on dibromomethane could not be obtained from the literature.
Metabolism- Dibromomethane was metabolized to carbon monoxide and inorganic bromidein vitroin the presence of rat hepatic microsomes, NADPH and molecular oxygen (Kubic and Anders, 1975, 1978). Microsomes from rat pulmonary and renal microsomes showed ~18 and ~5 %, respectively of the activity of the hepatic microsomes. Brain and splenic microsomes did not metabolize dibromomethane to carbon monoxide and inorganic bromide.
In vitrostudies with inhibitors and stimulators of cytochrome P-450 activity indicate that a cytochrome P-450 system is involved in the metabolism (Kubic and Andreas, 1975, Stevenes et al 1980).
Kubic and Ander (1975) confirmed that in the cytosolthe metabolic pathway of dihalomethane is to formaldehyde and inorganic bromide.
Administration of dibromomethane to ratsin vivoresulted in increased levels of carboxyhemoglobin, indicating metabolism of dibromomethane to carbon monoxide and inorganic bromide (Kubic et al. (1974).
Kubic et al (1974) administered 3 mmol/ kg (522mg/kg) dibromomethane by intraperitoneal injection to young adult male long-Evans rats and measured the increase in blood carboxyhemoglobin levels for 10 hours. At 4-5 hours, the carboxyhemoglobin level picked at ~14% of the total carboxyhemoglobin content of dibromomethane in rats. The level then declined in a biphasic manner over the next 5-6 hours. When the rats were injected intraperitoneally with 3 mmol/ kg dibromomethane once daily for 4 days, no evidence of accumulation of carboxyhemoglobin was found.
In dermal exposure experiments by McDougl et al (1985), the bromide ion concentrations in plasma increased with increasing exposure concentration in a nonlinear manner, indicating that the metabolism of dibromomethane to inorganic bromide may become saturated at high exposure concentrations.
Rodkey and Collison (1977) reported that the rate of carbon monoxide exhalation by female rats exposed by inhalation to 100mmol/kg of dibromomethanefor up to 6 hours was increased 51 times above the rate of carbon monoxide exhalation by untreated rats.
Excretion-
The amount of carbon mono oxide exhaled by female rats which were exposed to dibromomethane increased (Rodkey and Collison, 1977), data regarding the percent of an oral or inhalation dose excreted from the body and feces, urine bile expired air or sweat could not be located in the available literature.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.